Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it. The Food and Drug Administration (FDA) has updated ...

Metronomic chemotherapy with capecitabine (Xeloda) plus an aromatase inhibitor (AI) could be a first-line treatment option for some patients with HR-positive, HER2-negative metastatic breast cancer, ...

This patient presented with a moderately differentiated adenocarcinoma of the sigmoid colon, and was found to have intra-abdominal dissemination at the time of surgical resection. Tumor nodules in the ...

Intravenous bolus fluorouracil plus leucovorin is the standard adjuvant treatment for colon cancer. The oral fluoropyrimidine capecitabine is an established alternative to bolus fluorouracil plus ...

Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a ...